<DOC>
	<DOCNO>NCT01343745</DOCNO>
	<brief_summary>The aim exploratory investigation evaluate Forced Expiratory Volume 1st second ( FEV1 ) measurement , fractional exhale nitric oxide ( FENO ) Provocative Concentration 20 ( PC20 ) Adenosine Monophosphate ( AMP ) bronchial challenge evaluate administration fix combination Long-acting Beta-2-agonist ( LABA ) Inhaled Corticosteroid ( ICS ) increase dos may suitable demonstrate dose response .</brief_summary>
	<brief_title>Dose Response AMP Challenge Study With Beclometasone Dipropionate ( BDP ) /Formoterol Pressurised Metered Dose Inhaler ( pMDI )</brief_title>
	<detailed_description />
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>1 . Male female patient 1850 year age , sign informed consent form . 2 . Clinical evidence asthma 3 . Steroid na√Øve asthmatic patient 4 . FEV1 Screening Visit &gt; 70 % predict value least 2.0 L. 5 . Body Mass Index 18 35 . 6 . Sensitivity AMP Screening Visit . 7 . FENO level &gt; 25 ppb Screening Visit 1 . Having receive investigational product within 2 month Screening Visit . 2 . Inability comply study procedure study treatment intake . 3 . Any significant lung disease consider investigator clinically significant . 4 . Patients suffer Chronic Obstructive Pulmonary Disease ( COPD ) 5 . Previous current smoker smoke history great 5 pack year . 6 . Patients uncontrolled disease might , judgment investigator , place patient undue risk potentially compromise result interpretation study . 7 . Patients QTc &gt; 450msec Screening Visit . 8 . Patients serum potassium &lt; 3.5 mEq/L &gt; 6 mEq/L . 9 . Intolerance/hypersensitivity contraindication treatment beta2agonists and/or inhaled corticosteroid . 10 . Patients history alcohol substance abuse opinion Investigator may clinical significance . 11 . Patients undergone major surgery previous 3 month . 12 . Patients exacerbation asthma , require treatment oral steroid last month prior Screening Visit . 13 . Patients treat slowrelease corticosteroid 2 month prior Screening Visit . 14 . Patients currently treat antiIgE Antibodies . 15 . Patients respiratory tract infection within 4weeks prior Screening Visit . 16 . Females willing use effective contraceptive measure oral contraceptive intrauterine device ( IUD ) . 17 . Females pregnant , lactate plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>